Advertisement

The Scientist

» HIV, cell & molecular biology and immunology

Most Recent

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Grading on the Curve

Grading on the Curve

By | June 1, 2012

Actin filaments respond to pressure by forming branches at their curviest spots, helping resist the push.

5 Comments

image: Messing with HIV

Messing with HIV

By | June 1, 2012

Sangamo Biosciences is putting a different spin on gene therapy. 

0 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Breast Milk Antibodies Fight HIV

Breast Milk Antibodies Fight HIV

By | May 30, 2012

The anti-HIV antibodies from mothers carrying HIV could be used to help develop a vaccine.

0 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Cancer Exosomes Promote Metastasis

Cancer Exosomes Promote Metastasis

By | May 29, 2012

Vesicles released by melanoma cells stimulate pro-metastasis behaviors in bone marrow cells.

2 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

Check out the 10 images that won FASEB's first annual Bio-Art competition.

0 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Bina Technologies
Bina Technologies
Advertisement
The Scientist